ScholarIQanswers from OpenAlex
St. John's National Academy of Health Sciences
InstitutionResearch output, impact & collaborations
St. John's National Academy of Health Sciences is a institution indexed in ScholarIQ from OpenAlex.
What is known about St. John's National Academy of Health Sciences?
ScholarIQrecord summary
St. John's National Academy of Health Sciences is a research organisation in Bengaluru, IN. OpenAlex records 1,645 works and 94,346 citations for it. 573 researchers list it as their most recent affiliation.
How many works does St. John's National Academy of Health Sciences have?
ScholarIQindexed works
St. John's National Academy of Health Sciences has 1,645 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does St. John's National Academy of Health Sciences have?
ScholarIQcitation count
St. John's National Academy of Health Sciences has 94,346 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at St. John's National Academy of Health Sciences?
ScholarIQresearcher count
St. John's National Academy of Health Sciences has 573 researchers in the ScholarIQ index.
What is the average h-index at St. John's National Academy of Health Sciences?
ScholarIQavg h-index
St. John's National Academy of Health Sciences has an average h-index of 31.8 in OpenAlex.
What is the ROR of St. John's National Academy of Health Sciences?
ScholarIQror
The ROR for St. John's National Academy of Health Sciences is on the source record.
What is the OpenAlex record for St. John's National Academy of Health Sciences?
ScholarIQopenalex
The OpenAlex for St. John's National Academy of Health Sciences is on the source record.
Who are the most-cited researchers behind St. John's National Academy of Health Sciences?
ScholarIQtop researchers by citations
What are the most-cited papers on St. John's National Academy of Health Sciences?
ScholarIQmost cited works
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study
Martin O’Donnell, Denis Xavier, Lisheng Liu, Hongye Zhang, Siu Lim Chin, Rao Ps, Sumathy Rangarajan, Shofiqul Islam, Prem Pais, Matthew McQueen, Charles Mondo, Albertino Damasceno, Patricio López‐Jaramillo, Graeme J. Hankey, Antonio L Dans, Khalid Yusoff, Thomas Truelsen, Hans‐Christoph Diener, Ralph L. Sacco, Danuta Ryglewicz, Anna Członkowska, Christian Weimar, Xingyu Wang, Salim Yusuf
Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study
Martin O’Donnell, Siu Lim Chin, Sumathy Rangarajan, Denis Xavier, Lisheng Liu, Hongye Zhang, Rao Ps, Xiaohe Zhang, Prem Pais, Steven Agapay, Patricio López‐Jaramillo, Albertino Damasceno, Peter Langhorne, Matthew McQueen, Annika Rosengren, Mahshid Dehghan, Graeme J. Hankey, Antonio L Dans, Ahmed ElSayed, Álvaro Avezum, Charles Mondo, Hans‐Christoph Diener, Danuta Ryglewicz, Anna Członkowska, Nana Pogosova, Christian Weimar, Romaina Iqbal, Rafael Díaz, Khalid Yusoff, Afzalhussein Yusufali, Aytekin Oğuz, Xingyu Wang, Ernesto Peñaherrera, Fernando Laņas, Okechukwu S. Ogah, Adesola Ogunniyi, Helle K. Iversen, Germán Málaga, Zvonko Rumboldt, Shahram Oveisgharan, F Hussain, Daliwonga Magazi, Yongchai Nilanont, John Ferguson, Guillaume Paré, Salim Yusuf
Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data
Denis Xavier, Prem Pais, P.J. Devereaux, Changchun Xie, Dorairaj Prabhakaran, K. Srinath Reddy, Rajeev Gupta, Prashant Joshi, Prafulla Kerkar, Sadagopan Thanikachalam, KK Haridas, T M Jaison, Sudhir Naik, Maity Ak, Salim Yusuf
Lipid Profile, Plasma Apolipoproteins, and Risk of a First Myocardial Infarction Among Asians
Ganesan Karthikeyan, Koon Teo, Shofiqul Islam, M J McQueen, Prem Pais, Xingyu Wang, Hiroshi Sato, Chim C. Lang, Chitr Sitthi‐Amorn, M. R. Pandey, Khawar Kazmi, John E. Sanderson, Salim Yusuf
Design and baseline characteristics of participants in the <scp>R</scp> esearching cardiovascular <scp>E</scp> vents with a <scp>W</scp> eekly <scp>IN</scp> cretin in <scp>D</scp> iabetes ( <scp>REWIND</scp> ) trial on the cardiovascular effects of dulaglutide
Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, Rafael Díaz, Mark Lakshmanan, Prem Pais, Jeffrey L. Probstfield, Matthew C. Riddle, Lars Rydén, Denis Xavier, Charles Atisso, Álvaro Avezum, Jan Basile, Namsik Chung, Ignacio Conget, William C. Cushman, Edward Franek, Nicolae Hâncu, M Hanefeld, Shaun Holt, Petr Janský, Mátyás Keltai, Fernando Laņas, Lawrence A. Leiter, Patricio López‐Jaramillo, Ernesto Germán Cardona-Muñóz, Valdis Pīrāgs, Nana Pogosova, Peter Raubenheimer, Jonathan E. Shaw, Wayne Huey‐Herng Sheu, Theodora Temelkova‐Kurktschiev, on behalf of the REWIND Trial Investigators
How much of the research on St. John's National Academy of Health Sciences is open access?
ScholarIQopen access share
58%OPEN ACCESS